Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01591213 · ClinicalTrials.gov registry record

St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)

A clinical trial, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
426
Enrollment target

NCT01591213: Completed study, sponsored by St. Jude Children's Research Hospital.

NCT01591213 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 426 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01591213 has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
426 participants
Enrollment target

Study Summary

-The St. Jude Cancer Education for Children Program was created in 2006 as part of the outreach mandate of the Comprehensive Cancer Center at St. Jude Children's Research Hospital. The curriculum is designed to teach schoolchildren about cancer and dispel common misconceptions, inform students about healthy lifestyle choices that can translate to reduced cancer risk in adulthood, and to inspire an interest in science and scientific careers. In the 2010-2011 school year, researchers examined the impact of the program in regard to knowledge. It has always been clear that St. Jude personnel are limited to visiting a small number of schools in person each year so in 2011, a teacher's kit to the education program was created. The kit includes all the lesson plans needed to complete the program without the presence of St. Jude staff members. As a result, researchers at St. Jude Children's Research Hospital want to test the feasibility of the intervention by schoolteachers, and how this mechanism of delivery will affect student knowledge, attitudes, and health behaviors associated with cancer and healthy living.

Primary Outcome

Delivery of the educational curriculum by classroom teachers will be demonstrated to be a feasible method of delivering the St. Jude Cancer Education for Children Program. The program will be determined to be feasible if 80% of the schools that agree to participate complete the delivery of the program. A complete delivery will be defined as all grade consenting teachers delivering 2/3 of the educational content in each of the three modules.

Trial Details

FieldValue
Enrollment Target 426 participants
Start Date 2012-11
Est. Completion 2014-03

What the finished NCT01591213 record still lists

NCT01591213 is an observational study that tracks outcomes without assigning an intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01591213 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01591213 about?

NCT01591213 is a clinical study titled "St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)". -The St. Jude Cancer Education for Children Program was created in 2006 as part of the outreach mandate of the Comprehensive Cancer Center at St. Jude Children's Research Hospital. The curriculum is designed to teach schoolchildren about cancer and dispel common misconceptions, inform students about...

What is the current status of trial NCT01591213?

This trial is currently completed. The enrollment target is 426 participants. The study started on 2012-11. Estimated completion is 2014-03.

Who is sponsoring clinical trial NCT01591213?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790784 · 426 participants · Phase 3

    Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  • NCT04265430 · 425 participants · Phase 4

    Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

  • NCT04278690 · 425 participants · NA

    Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

  • NCT05321368 · 425 participants · NA

    A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01591213, the US trial registry maintained by the National Library of Medicine. NCT01591213 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.